Archon Capital Management LLC 13D and 13G filings for Neuronetics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-08-14 6:17 pm Sale | 2024-08-12 | 13G | Neuronetics, Inc. STIM | Archon Capital Management LLC | 922,443 3.000% | -1,614,654 (-63.64%) | Filing |
2024-02-13 11:10 am Sale | 2023-12-31 | 13G | Neuronetics, Inc. STIM | Archon Capital Management LLC | 2,537,097 8.770% | -340,609 (-11.84%) | Filing |
2023-08-22 5:57 pm Purchase | 2023-08-14 | 13G | Neuronetics, Inc. STIM | Archon Capital Management LLC | 2,877,706 9.970% | 1,051,900 (+57.61%) | Filing |
2023-02-13 2:37 pm Sale | 2022-12-31 | 13G | Neuronetics, Inc. STIM | Archon Capital Management LLC | 1,825,806 6.710% | -28,609 (-1.54%) | Filing |
2022-02-14 4:33 pm Purchase | 2021-12-31 | 13G | Neuronetics, Inc. STIM | Archon Capital Management LLC | 1,854,415 7.030% | 789,995 (+74.22%) | Filing |
2021-02-12 8:22 pm Purchase | 2020-12-31 | 13G | Neuronetics, Inc. STIM | Archon Capital Management LLC | 1,064,420 5.610% | 1,064,420 (New Position) | Filing |